Product image of Erlotinib Krka (Erlotinib) supplied by GNH India

Erlotinib Krka

Active Ingredient:
Erlotinib
Origin:
EU

Erlotinib Krka (Erlotinib)

Erlotinib Krka is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer treatment.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Erlotinib Krka is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often prescribed as part of a comprehensive cancer treatment plan.

Side Effects

  • Common effects of Erlotinib Krka may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss, nausea, or dry skin. These effects can vary in intensity and duration, and it's important to monitor any changes in your health while taking this medication.

Precautions & Warnings

  • Erlotinib Krka should be handled with care, especially if you have a history of severe allergic reactions to similar medications. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. Always store this medication in a cool, dry place away from direct sunlight.

Avoid Interactions

  • Erlotinib Krka may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.

Frequently Asked Questions

Erlotinib Krka is used to treat certain types of cancer, including non-small cell lung cancer and pancreatic cancer.

Erlotinib Krka is taken orally, typically once daily. Follow the specific instructions provided by your healthcare professional.

Common side effects may include skin rash, diarrhea, fatigue, appetite loss, nausea, and dry skin.

Erlotinib Krka may interact with other medications, so it's important to consult your healthcare provider before combining it with other treatments.

Erlotinib Krka should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Erlotinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT